A3Z-20937-07673
3 vaccinations
2 coded responses
27 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 077 / NJ
- Registered
- 2021-02-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Registered in v-safe
-
2021-02-25
Dose 1 — Pfizer-BioNTech
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-03-18
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
-
2021-06-17
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: A cold. Running nose, congestion, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-16
-
2021-12-02
Dose 3 — Moderna
- 2022-03-18
-
2022-06-02
Survey response — 6 months, dose 3MedDRA: Gestational diabetes, Hypothyroidism — Feeling: GoodFree text: Gestational diabetes Pregnancy induced hypothyroidismMedDRA releases: 2024-11 · check-in free text available
- 2022-12-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Moderna | No |
Free text
Release 9 — 3 months, dose 2
Symptoms: A cold. Running nose, congestion, sore throat
Release 11 — 6 months, dose 3
Symptoms: Gestational diabetes Pregnancy induced hypothyroidism
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational diabetes | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release